Farms.com Home   News

Tariffs Put U.S. Farmers in Jeopardy

North Dakota farmer Kevin Skunes, president of the National Corn Growers Association (NCGA), made the following statement after the White House announced plans to impose tariffs on steel and aluminum imports from the European Union, Canada and Mexico, triggering potential retaliatory actions against American agriculture.
 
“Farmers are busy with planting season but are moving forward without knowing who will buy their crop when it’s harvested later this year. With a 52 percent drop in net farm income over the last five years, and depressed commodity prices, this is not the time to face such a burden. This uncertainty impacts every step of the agriculture economy, from securing financing to marketing.
 
“Imposing tariffs has the potential to undermine positive relationships with our closest allies and erode long-standing market access. NCGA urges policymakers to strengthen cooperation with our trading partners and stay at the negotiating table.”
 

Trending Video

Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Video: Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Regulations help markets and industry exist on level playing fields, keeping consumers safe and innovation from going too far. However, incredibly strict regulations can stunt innovation and cause entire industries to wither away. Dr. Peter James Facchini brings his perspective on how existing regulations have slowed the advancement of medical developments within Canada. Given the international concern of opium poppy’s illicit potential, Health Canada must abide by this global policy. But with modern technology pushing the development of many pharmaceuticals to being grown via fermentation, is it time to reconsider the rules?

Dr. Peter James Facchini leads research into the metabolic biochemistry in opium poppy at the University of Calgary. For more than 30 years, his work has contributed to the increased availability of benzylisoquinoline alkaloid biosynthetic genes to assist in the creation of morphine for pharmaceutical use. Dr. Facchini completed his B.Sc. and Ph.D. in Biological Sciences at the University of Toronto before completing Postdoctoral Fellowships in Biochemistry at the University of Kentucky in 1992 & Université de Montréal in 1995.